甲草胺诱导的小鼠甲状腺腺瘤样结节来源细胞系的建立与鉴定
研究从甲草胺处理小鼠的甲状腺腺瘤样结节中建立了5株细胞系(CAT),其中CAT458s和CAT459具上皮标志物阳性、间充质标志物阴性。NKX2-1过表达可诱导部分甲状腺分化标志物表达,IGF-I信号可转导且NVP-ADW742抑制增殖,两株细胞均无致瘤性,全基因组测序发现Polk和Tgfb1错义突变但Braf、Trp53、Tert无突变。
要点
- 建立了5株小鼠甲状腺腺瘤样结节来源细胞系,CAT458s和CAT459为上皮样且无致瘤性。
- NKX2-1过表达可增加和/或诱导CAT459及CAT458s的甲状腺分化标志物表达。
- 全基因组测序显示Polk和Tgfb1错义突变,Braf、Trp53、Tert无突变。
核心结论
- 建立了2株甲状腺分化标志物表达不同的小鼠甲状腺腺瘤样结节来源细胞系,NKX2-1可诱导其部分分化。
- 两株细胞无致瘤性且缺乏甲状腺癌相关基因的显著突变,但全基因组测序发现部分抑癌基因错义突变。
- CAT458s和CAT459为阐明甲状腺多步骤癌变与分化过程提供了新工具。
研究设计与样本
- 从甲草胺处理小鼠的甲状腺腺瘤样结节中建立细胞系,检测上皮、间充质及甲状腺标志物表达。
- 通过慢病毒转导过表达NKX2-1,检测甲状腺标志物表达变化。
- 用IGF-I及选择性IGF-IR抑制剂NVP-ADW742处理,评估信号转导与细胞增殖。
- 进行小鼠异种移植研究评估致瘤性,并用全基因组测序分析两株细胞系的基因突变。
主要发现
- 建立5株小鼠甲状腺腺瘤样结节来源细胞系,命名为CAT(细胞来自甲草胺处理甲状腺)。
- CAT458/458s(CAT458s为CAT458亚系)和CAT459为上皮标志物阳性、间充质标志物阴性。
- NKX2-1阳性CAT459细胞较NKX2-1阴性CAT458s细胞某些甲状腺分化标志物mRNA表达更高,NKX2-1过表达增加和/或诱导其表达。
- 促甲状腺激素受体(Tshr)阴性CAT458s和459细胞可转导IGF-I信号,NVP-ADW742抑制其增殖。
- 皮下注射CAT458s或459细胞后小鼠未发生肿瘤;全基因组测序发现Polk和Tgfb1等抑癌基因错义突变,Braf、Trp53、Tert无突变。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: Thyroid cancer cell lines have been of great value for the study of thyroid cancer. However, the availability of benign thyroid adenoma cell lines is limited. Methods: Cell lines were established from thyroid adenomatous nodules that developed in mice treated with the goitrogen amitrole. Expression of epithelial, mesenchymal, and thyroid markers of these established cell lines was determined, and the effect of lentivirus-transduced overexpression of NKX2-1, a master regulator of thyroid development, on the thyroid marker expression was examined. Signal transduction and cell proliferation were evaluated after treatment with insulin-like growth factor-I (IGF-I) and the selective IGF-I receptor (IGF-IR) inhibitor NVP-ADW742. Xenograft studies were performed to examine tumorigenicity of the cells in mice. Whole-genome sequencing (WGS) was used to comprehensively determine the genetic mutations in the established two cell lines. Results: Five mouse thyroid adenomatous nodules-derived cell lines named CAT (cells from amitrole-treated thyroids) were established. Among these, two cell lines, CAT458/458s (CAT458s: a subline of CAT458) and CAT459, were found to be positive for epithelial markers and negative for a mesenchymal marker. NKX2-1-positive CAT459 cells showed higher messenger RNA (mRNA) expression of some thyroid differentiation markers than NKX2-1-negative CAT458s cells, and NKX2-1 overexpression increased and/or induced their expression. IGF-I signaling was transduced in thyrotropin receptor (Tshr)-negative CAT458s and 459 cells, and NVP-ADW742 suppressed their proliferation. No tumors developed in mice after subcutaneous injection of CAT458s or 459 cells. The WGS analysis revealed the presence of missense mutations in the tumor suppressor genes such as Polk (encoding DNA polymerase kappa) and Tgfb1 (encoding transforming growth factor beta 1), while no mutations were found in the prominent thyroid cancer-related genes Braf, Trp53 (encoding p53), and Tert (encoding telomerase reverse transcriptase). Conclusions: Two mouse thyroid adenomatous nodule-derived cell lines with different thyroid differentiation marker expression were established. NKX2-1 induced partial differentiation of these cell lines. They lacked tumorigenicity and prominent gene mutations involved in thyroid cancer development, while missense mutations were found in some tumor suppressors as revealed by WGS. The CAT458s and 459 provide a new tool to further clarify the process of thyroid multistep carcinogenesis and differentiation.
引用
- Shirai YT, Hoshi N, Ward JM, et al. Establishment and Characterization of Amitrole-Induced Mouse Thyroid Adenomatous Nodule-Derived Cell Lines. Thyroid. 2024. PMID: 38149583. doi:10.1089/thy.2023.0341
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。